Also known as: Sibelium (brand)
Flunarizine is a selective calcium entry blocker used for the prophylactic treatment of migraine, vertigo, and peripheral vascular disease. It blocks voltage-dependent calcium channels and exhibits antihistaminic and dopamine D2 receptor blocking properties.
Mediocon Inc supplies Flunarizine IP/BP/USP as a pharmaceutical-grade API for manufacturers producing antimigraine and neurological formulations. With robust quality controls and GMP-certified manufacturing, we ensure consistent purity and efficacy in every batch.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | NLT 98.0% & NMT 102.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 10 ppm |
| Residual Solvents | Complies ICH Q3C |
| Microbial Limits | Complies |
| Identification | HPLC & IR Compliant |
| Melting Point | 252 – 256 °C |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Flunarizine (CAS 52468-60-7) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Flunarizine is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance